Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
71.16 USD | +1.25% | +7.15% | -3.84% |
May. 17 | Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing | MT |
May. 16 | Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.84% | 4.54B | |
+52.09% | 55.7B | |
+41.08% | 39.91B | |
-6.03% | 39.57B | |
-5.56% | 28.16B | |
+15.54% | 26.3B | |
-19.86% | 18.94B | |
+31.36% | 12.17B | |
+26.51% | 12.12B | |
+1.50% | 12.12B |
- Stock Market
- Equities
- NUVL Stock
- News Nuvalent, Inc.
- Wedbush Raises Nuvalent's PT to $82 From $74 After Announced 3-Year Plan to Place At Least One Lead Asset on Market by 2026; Keeps Outperform Rating